Treating gastric cancer cells with DS or silencing HIF-1α can significantly inhibit the volume and number of metastatic tumors in a mouse model of gastric cancer and suppress TGF-β-mediated EMT [80]. This evidence concerns the gene HIF1A and gastric cancer.